Therapeutic drug monitoring of anti-tumour necrosis factor agents in inflammatory bowel diseases: The jury is still out

Research output: Contribution to journalEditorial

2 Scopus citations
Original languageEnglish
Pages (from-to)1035-1036
Number of pages2
JournalJournal of Crohn's and Colitis
Issue number8
StatePublished - 1 Aug 2020


  • Blood biomarker
  • Clinical remission
  • Crohn's disease
  • Disease monitoring
  • Inflammatory bowel diseases
  • Non-invasive biomarker
  • Proactive drug monitoring
  • Reactive drug monitoring
  • Therapeutic drug monitoring
  • Treat-to-target

Cite this